Palliative care in BMT.
The field of high-dose therapy and SCT has made many advances in the past several years and the success rates have been steadily increasing as newer therapies emerge and improvements in supportive care continue to improve patient survival and cure rates. There still remains a mortality risk for high-dose therapy and the need for palliative care becomes more apparent as the focus also incorporates quality of life in all facets of cancer treatment and care. This paper reports on the lack of literature available on palliative care into the BMT and explores areas of future research in the integration of these two fields of medicine.
Chung
H M
HM
Department of Internal Medicine, Division of Hematology/Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Lyckholm
L J
LJ
Smith
T J
TJ
D016026:Bone Marrow Transplantation / Q000379:methods*; D006801:Humans; D010166:Palliative Care / Q000379:methods*